Clinical Trial Update: Bioequivalence Study of Two Imiquimod Cream 5% [Phase 1]

View source ↗

Summary

This trial update reports a Phase 1 bioequivalence study comparing two Imiquimod 5% creams for actinic keratosis. The study status is completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod Cream 5% (imiquimod)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED | Results posted: 2009-11-26